Single-cell Omics Market Trends

Single-cell Omics Market Trends

The increasing prevalence of cancer will significantly boost the market. For instance, according to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. Similarly, according to the Canadian Cancer Society, 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime. Approximately 1 in 4 Canadians is expected to die of the disease. As cancer rates continue to rise, traditional treatment approaches face challenges in effectively targeting the heterogeneous nature of tumours. Single-cell omics, with its capability to analyse individual cells within tumours, offers a transformative solution that aligns seamlessly with the demands of precision medicine.